Skip to main content
Clinical Trials/NCT00226928
NCT00226928
Completed
Not Applicable

Psychosocial Treatment Effects on Cancer Survival

Stanford University0 sites125 target enrollmentSeptember 27, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stage IIIB, IV, Recurrent, and Metastatic Breast Cancer
Sponsor
Stanford University
Enrollment
125
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

This study will investigate the influence of psychosocial treatment on psychological outcomes and survival among women with metastatic or recurrent breast cancer.

Detailed Description

The objective of this study is to investigate the influence of psychosocial treatment on psychological outcomes and survival among women with metastatic/recurrent breast cancer.

Registry
clinicaltrials.gov
Start Date
September 27, 2005
End Date
July 2005
Last Updated
12 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Spiegel

Jack, Lulu & Sam Willson Professor

Stanford University

Eligibility Criteria

Inclusion Criteria

  • Women were eligible for the study if they had documented metastatic or recurrent breast cancer, were proficient enough in English to be able to complete questionnaires and participate in a support group, were living in the Greater San Francisco Bay Area, and had a Karnofsky score of at least 70%.19

Exclusion Criteria

  • Women were excluded if they had any of the following risk factors: positive supraclavicular lymph nodes as the only metastatic lesion at the time of initial diagnosis; active non-breast cancers within the past 10 years; or other concurrent medical conditions likely to influence short-term survival. Basal cell or squamous cell carcinomas of the skin, in situ cancer of the cervix, or melanoma with a Breslow depth less than 0.76 mm were allowed.

Outcomes

Primary Outcomes

Not specified

Similar Trials